Dorzolamide Hydrochloride Timolol Maletae Solution/ Drops
Product Images NDC 14445-405

2 FDA label images from Indoco Remedies Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride Timolol Maletae (NDC 14445-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indoco Remedies Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2021 (Dorzotimo Carton)

2021 (Dorzotimo Carton)
Packaging label for Dorzolamide HCl/Timolol Maleate ophthalmic solution, USP, 22.3 mg/6.8 mg per mL, 10 mL bottle. The label indicates the product is sterile, Rx only, and for use in the eyes only. It includes dosage information, storage instructions, and manufacturer details (Indoco Remedies Limited, Verna, Goa, India). The label features a barcode and regulatory information.*
FDA Label Image

2022 (Dorzotimo Container)

2022 (Dorzotimo Container)
Label for Dorzolamide HCl/Timolol Maleate ophthalmic solution, USP, containing 22.3 mg/6.8 mg per mL. The 10 mL bottle label shows Indoco Remedies Limited as manufacturer, includes dosing information, storage instruction to protect from light, and a barcode. The label indicates the solution is for use in the eyes only and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.